<DOC>
	<DOCNO>NCT01304251</DOCNO>
	<brief_summary>The purpose study determine effect short-term fasting tolerance adjuvant chemotherapy breast cancer patient</brief_summary>
	<brief_title>Effects Short-term Fasting Tolerance Chemotherapy</brief_title>
	<detailed_description>Evidence experimental animal provide strong support concept caloric restriction ( CR ) increase resistance multiple form stress . CR decrease plasma level growth factor , e.g . insulin-like growth factor-I ( IGF-I ) , thereby divert energy growth maintenance . Accordingly , currently available information suggest short-term fasting protects normal cell peril ( high dose ) chemotherapy . In contrast , cancer cell ( less ) protect result self-sufficiency growth signal . This phenomenon term Differential Stress Resistance ( DSR ) . DSR reduce severity side-effects cause toxicity chemotherapy , without interfere effect reduction tumour volume tumour marker . A recent report , sketch case series 10 cancer patient , suggest short term fast protects side effect chemotherapy human . Indeed , majority patient prefer fast feed preparation therapy . This study aim evaluate impact fast tolerance chemotherapy human .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female breast cancer patient , receive adjuvant TACchemotherapy Age ≥ 18 year old WHO performance status 02 Adequate bone marrow function : white blood cell ( WBCs ) ≥ 3.0 x 109/l , neutrophil ≥ 1.5 x 109/l , platelet ≥ 100 x 109/l Adequate liver function : bilirubin ≤ 1.5 x upper limit normal ( UNL ) range , ALAT and/or ASAT ≤ 2.5 x UNL , Alkaline Phosphatase ≤5 x UNL Adequate renal function : calculated creatinine clearance ≥ 50 mL/min Survival expectation &gt; 3 month Patients must accessible treatment followup Written inform consent accord local Ethics Committee requirement Serious diseases recent myocardial infarction , clinical sign cardiac failure clinically significant arrhythmia Diabetes Mellitus body mass index ( BMI ) &lt; 19 kg/m2 Pregnancy lactate Medical psychological condition opinion investigator would permit patient complete study sign meaningful inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>short-term fasting</keyword>
	<keyword>adjuvant chemotherapy</keyword>
	<keyword>toxicity</keyword>
	<keyword>side-effects</keyword>
</DOC>